J B Chemicals & Pharmaceuticals Limited has amalgamated with Torrent Pharmaceuticals Limited effective July 8, 2026. The scheme became legally binding after both entities filed certified copies of the National Company Law Tribunal (NCLT) order with the Registrar of Companies, Ahmedabad. Consequently, J B Chemicals stands dissolved without being wound up. The appointed date for the amalgamation is January 21, 2026.

The NCLT, Ahmedabad Bench, sanctioned the scheme via an order dated July 6, 2026. The certified copy of this order was received on July 7, 2026. The scheme operates under Sections 230 to 232 of the Companies Act, 2013, and outlines a share exchange ratio of 51 fully paid-up equity shares of Torrent Pharma (face value ₹5 each) for every 100 fully paid-up equity shares of J B Chemicals (face value ₹1 each).

The disclosure regarding the effective date was made to BSE Limited and National Stock Exchange of India Ltd. under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing confirms the completion of the statutory filing process required to operationalize the scheme.

Torrent Pharmaceuticals has confirmed that it, along with persons acting in concert (PAC), did not create any encumbrance on the shares of J B Chemicals & Pharmaceuticals Limited during the financial year ended March 31, 2026. This declaration ensures that the shares held by the acquirer remain free from charges such as pledges or hypothecation, providing clarity to shareholders regarding the status of the stake.

The disclosure was filed pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires acquirers to inform the stock exchanges if any encumbrance has been created on the shares of the target company during a financial year. The confirmation was submitted by Chintan M. Trivedi, Company Secretary of Torrent Pharmaceuticals Limited.

The notification was addressed to the Corporate Relationship Department of BSE Limited and the Listing Department of National Stock Exchange of India Limited. Copies of the declaration were also forwarded to the Company Secretary and the Audit Committee of J B Chemicals & Pharmaceuticals Limited for their records.